Atossa Therapeutics, Inc. ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced ...

Increasingly concerned that Texas will lose more college students and has already missed numerous opportunities to recruit the best and brightest University professors testified in a public hearing ...

And in the hair world things are shifting, judging by current trends on TikTok and Pinterest and among our celebrity friends.

Simmons asked Scripps News anchor Maritsa Georgiou if she "was still modeling" at the end of their wide-ranging interview ...

New research published in Brain, Behavior, and Immunity provides evidence that alcohol use disorder triggers a distinct type ...

Armed with some data from our friends at CrunchBase, I broke down the largest NYC Startup funding rounds in New York for November 2025. I have included some additional information such as industry, ...

In this interview, George Eastwood, executive director of the Emily Whitehead Foundation and CAR T Vision steering committee member discusses barriers and strategies for expanding access to CAR T-cell ...

Experience Hong Kong City as the sun rises over Victoria Harbour, casting light across one of the world’s most iconic skylines. Captured in ultra-high-definition, this aerial footage reveals the ...

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction ...

It feels like every day there’s a new breakthrough in life sciences, and a lot of that has to do with companies like Resolve ...

New Street Research’s Blair Levin wrote in a research note on Friday that the Trump Department of Justice is “more likely than not” to challenge the deal, but there are steps that Netflix could take, ...